EUROAPI
LIVE

Serial Number

90302923

Owner

SANOFI

Attorney

Karen Lim

Filing Date

Nov 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EUROAPI Trademark

Serial Number: 90302923 • Registration: 6566226

EUROAPI is a trademark filed by SANOFI on November 6, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SANOFI (1,104 trademarks)

Paris 75017 , FR

Entity Type: 03

EUROAPI (5 trademarks)

15 RUE TRAVERSIÈRE

Entity Type: 99

Trademark Details

Filing Date

November 6, 2020

Registration Date

November 23, 2021

Published for Opposition

September 7, 2021

Goods & Services

Treatment of chemicals, namely, custom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing

Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic foods adapted for medical use; bacterial preparations for medical and veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical use; food supplements for human beings and animals; disinfectants; biochemicals, namely, monoclonal antibodies for pharmaceutical use

Chemicals for use in industry and science

Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific and technical services, namely, scientific analysis of industrial installations; scientific research and development services in the field of pharmaceuticals; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical, chemical or agrochemical products; engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and pharmaceutical fields; engineering services for chemical and organic products and the processing thereof in the field of basic and industrial technology; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 29, 2022 ASGN
REGISTERED-PRINCIPAL REGISTER
Nov 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2021 CRFA
ASSIGNED TO LIE
Jul 29, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 26, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 16, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 16, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 16, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jan 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jan 21, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 20, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2021 NWOS
NEW APPLICATION ENTERED
Nov 10, 2020 NWAP